These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28263871)

  • 21. Ischemic stroke is associated with the pro-inflammatory potential of N-glycosylated immunoglobulin G.
    Liu D; Zhao Z; Wang A; Ge S; Wang H; Zhang X; Sun Q; Cao W; Sun M; Wu L; Song M; Zhou Y; Wang W; Wang Y
    J Neuroinflammation; 2018 Apr; 15(1):123. PubMed ID: 29699572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycomics for Type 2 Diabetes Biomarker Discovery: Promise of Immunoglobulin G Subclass-Specific Fragment Crystallizable N-glycosylation in the Uyghur Population.
    Liu J; Dolikun M; Štambuk J; Trbojević-Akmačić I; Zhang J; Zhang J; Wang H; Meng X; Razdorov G; Menon D; Zheng D; Wu L; Wang Y; Song M; Lauc G; Wang W
    OMICS; 2019 Dec; 23(12):640-648. PubMed ID: 31393219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in total plasma and serum N-glycome composition and patient-controlled analgesia after major abdominal surgery.
    Gudelj I; Baciarello M; Ugrina I; De Gregori M; Napolioni V; Ingelmo PM; Bugada D; De Gregori S; Đerek L; Pučić-Baković M; Novokmet M; Gornik O; Saccani Jotti G; Meschi T; Lauc G; Allegri M
    Sci Rep; 2016 Aug; 6():31234. PubMed ID: 27501865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter methylation of the
    Klasić M; Markulin D; Vojta A; Samaržija I; Biruš I; Dobrinić P; Ventham NT; Trbojević-Akmačić I; Šimurina M; Štambuk J; Razdorov G; Kennedy NA; Satsangi J; Dias AM; Pinho S; Annese V; Latiano A; D'Inca R; ; Lauc G; Zoldoš V
    Clin Epigenetics; 2018; 10():75. PubMed ID: 29991969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).
    Khera AV; Everett BM; Caulfield MP; Hantash FM; Wohlgemuth J; Ridker PM; Mora S
    Circulation; 2014 Feb; 129(6):635-42. PubMed ID: 24243886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the JUPITER trial on statin prescribing for primary prevention.
    Teng JF; Gomes T; Camacho X; Grundy S; Juurlink DN; Mamdani MM
    Pharmacotherapy; 2014 Jan; 34(1):9-18. PubMed ID: 23940007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival.
    Kodar K; Stadlmann J; Klaamas K; Sergeyev B; Kurtenkov O
    Glycoconj J; 2012 Jan; 29(1):57-66. PubMed ID: 22179780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes of IgG
    Trzos S; Link-Lenczowski P; Sokołowski G; Pocheć E
    Front Immunol; 2022; 13():841710. PubMed ID: 35370997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgG N-glycome changes during the course of severe COVID-19: An observational study.
    Petrović T; Vijay A; Vučković F; Trbojević-Akmačić I; Ollivere BJ; Marjanović D; Bego T; Prnjavorac B; Đerek L; Markotić A; Lukšić I; Jurin I; Valdes AM; Hadžibegović I; Lauc G
    EBioMedicine; 2022 Jul; 81():104101. PubMed ID: 35773089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin therapy and risk of fracture: results from the JUPITER randomized clinical trial.
    Peña JM; Aspberg S; MacFadyen J; Glynn RJ; Solomon DH; Ridker PM
    JAMA Intern Med; 2015 Feb; 175(2):171-7. PubMed ID: 25437881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of separation techniques for the elucidation of IgG N-glycans pooled from healthy mammalian species.
    Adamczyk B; Tharmalingam-Jaikaran T; Schomberg M; Szekrényes Á; Kelly RM; Karlsson NG; Guttman A; Rudd PM
    Carbohydr Res; 2014 May; 389():174-85. PubMed ID: 24680513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).
    Ridker PM; MacFadyen JG; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
    Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):616-23. PubMed ID: 20031900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of lipoprotein-associated phospholipase A₂ mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial.
    Ridker PM; MacFadyen JG; Wolfert RL; Koenig W
    Clin Chem; 2012 May; 58(5):877-86. PubMed ID: 22419750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between plasma protein, IgG and IgA N-glycosylation and metabolic health markers in pregnancy and gestational diabetes.
    Štambuk T; Kifer D; Smirčić-Duvnjak L; Vučić Lovrenčić M; Gornik O
    PLoS One; 2023; 18(4):e0284838. PubMed ID: 37079606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Region-Specific Cell Membrane N-Glycome of Functional Mouse Brain Areas Revealed by nanoLC-MS Analysis.
    Barboza M; Solakyildirim K; Knotts TA; Luke J; Gareau MG; Raybould HE; Lebrilla CB
    Mol Cell Proteomics; 2021; 20():100130. PubMed ID: 34358619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein.
    Ridker PM; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Khurmi NS; Koenig W; Libby P; Lorenzatti AJ; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
    Am J Cardiol; 2007 Dec; 100(11):1659-64. PubMed ID: 18036365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profiling of IgG N-glycome during mouse aging: Fucosylated diantennary glycans containing one Neu5Gc-linked LacNAc are associated with age.
    Han J; Pan Y; Gu Y; Xu X; Zhao R; Sha J; Zhang R; Gu J; Ren S
    J Proteomics; 2020 Oct; 229():103966. PubMed ID: 32891889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between galactosylation of immunoglobulin G and body mass index.
    Nikolac Perkovic M; Pucic Bakovic M; Kristic J; Novokmet M; Huffman JE; Vitart V; Hayward C; Rudan I; Wilson JF; Campbell H; Polasek O; Lauc G; Pivac N
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():20-5. PubMed ID: 24012618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia.
    Kostapanos MS; Milionis HJ; Elisaf MS
    Am J Cardiovasc Drugs; 2010; 10(1):11-28. PubMed ID: 20104931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome.
    Trbojević Akmačić I; Ventham NT; Theodoratou E; Vučković F; Kennedy NA; Krištić J; Nimmo ER; Kalla R; Drummond H; Štambuk J; Dunlop MG; Novokmet M; Aulchenko Y; Gornik O; Campbell H; Pučić Baković M; Satsangi J; Lauc G;
    Inflamm Bowel Dis; 2015 Jun; 21(6):1237-47. PubMed ID: 25895110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.